载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 江苏翔腾新材料股份有限公司（以下简称"公司"或"翔腾新材"）于2025年3月18 日在巨潮资讯网（www.cninfo.com.cn）及指定信息披露报刊上披露了《关于公司股 东减持股份预披露公告》（公告编号：2025-005）。自股份减持计划预披露公告之 日起15个交易日后的3个月内（即2025年4月10日起至2025年7月9日止），公司股东 余俊德先生计划通过集中竞价方式减持本公司股份不超过55,000股（占本公司总股 本比例0.08%）。 近日，公司收到余俊德先生出具的《关于减持股份实施情况告知函》，现将具 体情况公告如下： 一、股东减持情况 （一）股东减持股份情况 证券代码：001373 证券简称：翔腾新材 公告编号：2025-028 江苏翔腾新材料股份有限公司 公司股东余俊德保证向本公司提供的信息内容真实、准确、完整，没有虚假记 本次减持前持有股份 减持后持有股份 股东名称 股份性质 股数（股） 占总股本比例 股数（股） 占总股本比例 合计持有股份 220,135 0.32049% 165,135 0.24 ...

证券代码：001373 证券简称：翔腾新材 公告编号：2025-028 江苏翔腾新材料股份有限公司 关于股东减持股份实施情况的公告 公司股东余俊德保证向本公司提供的信息内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 江苏翔腾新材料股份有限公司（以下简称"公司"或"翔腾新材"）于2025年3月18 日在巨潮资讯网（www.cninfo.com.cn）及指定信息披露报刊上披露了《关于公司股 东减持股份预披露公告》（公告编号：2025-005）。自股份减持计划预披露公告之 日起15个交易日后的3个月内（即2025年4月10日起至2025年7月9日止），公司股东 余俊德先生计划通过集中竞价方式减持本公司股份不超过55,000股（占本公司总股 本比例0.08%）。 近日，公司收到余俊德先生出具的《关于减持股份实施情况告知函》，现将具 体情况公告如下： 一、股东减持情况 | 股东名称 | 减持方式 | 减持期间 | 减持均 | 减持价格区 | 减持股 | 减持比例 | | --- | --- | --- | --- | --- | --- ...

Group 1 - Huiyu Pharmaceutical's subsidiary received drug registration certificate for Carboxymethyl Sodium Injection, which is used for treating bleeding diseases in various medical fields [1] - Baihe Co., Ltd. announced a plan for a director to reduce holdings by up to 424,000 shares, representing 0.6625% of the total share capital [1] - Kingood Co., Ltd. received a notification from a global leading automaker for a wheel project, expected to start mass production in 2026 with a lifecycle of 10 years [1][2] Group 2 - Wanhua Chemical plans to repurchase shares worth between 300 million and 500 million yuan, with a maximum repurchase price of 99.36 yuan per share [2] - Warner Pharmaceutical's subsidiary received approval for Acetylcysteine raw material drug, primarily used for treating respiratory diseases [3] - ST Mingcheng plans to publicly transfer 45% equity of its subsidiary, aiming to optimize asset structure [4] Group 3 - Qixia Construction announced a plan to reduce up to 31.5 million shares, accounting for 3% of total share capital [5][6] - Zhejiang Rongtai intends to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - Yuandong Biological received drug registration for Chloral Hydrate Enema, used for sedation and seizure control in children [9] Group 4 - Jiemai Technology's subsidiary signed a strategic cooperation agreement with a solid-state battery company to produce high-safety composite conductive materials [10] - Xianju Pharmaceutical received drug registration for Progesterone Soft Capsules, used for treating functional disorders due to luteal deficiency [11] - Lanhua Kecai's subsidiary reported a temporary production halt, with the resumption date yet to be determined [13] Group 5 - Sinopharm Modern's subsidiary received drug registration for Tocilizumab Tablets, used for treating rheumatoid arthritis and other conditions [15] - Shanghai Bank announced the resignation of its vice president due to organizational adjustments [17] - Shanghai Pharmaceutical's Ephedrine Injection passed the consistency evaluation for generic drugs [19] Group 6 - Rundu Co., Ltd. received drug registration for Amlodipine and Olmesartan Tablets, aimed at treating hypertension [21] - Zhong'an Technology announced that 61 million shares held by its controlling shareholder will be auctioned [23] - Shanghai Washba plans to purchase patent assets and establish two subsidiaries focused on hydrogen energy and solid-state battery technologies [25] Group 7 - Nuo Cheng Jianhua's new drug Tafasitamab received approval for treating relapsed/refractory diffuse large B-cell lymphoma [26] - Benli Technology plans to use up to 200 million yuan of idle funds for cash management and financial investments [28] - Taiji Co., Ltd. intends to use 60 million yuan of idle funds to purchase financial products [29] Group 8 - Haishi Co. announced that its innovative drug Anreke Fen Injection received drug registration for treating postoperative pain [32] - Yulong Co. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [36] - Weifu High-Tech plans to establish a joint venture with Shanghai Baolong Automotive Technology [38] Group 9 - Xichang Electric Power expects a net profit reduction of approximately 5.4 million yuan due to adjustments in the time-of-use electricity pricing mechanism [39] - Alter signed a contract worth 6.8 billion yen for the development and procurement of large truck EV kits [41] - Zhonglian Heavy Industry plans to acquire controlling stakes in its financing leasing subsidiary through public bidding [42] Group 10 - Sanyou Medical's executive plans to reduce holdings by up to 1.44% of the company's shares [43] - Hangyang Co. plans to establish a subsidiary for large modular cryogenic equipment manufacturing with an estimated investment of 557 million yuan [44] - FAW Fuwi received a notification for a dashboard project from a well-known new energy brand, with total sales expected to reach 1.06 billion yuan [45]

Group 1 - Zhaoyi Innovation plans to issue H-shares and list on the Hong Kong Stock Exchange, considering the interests of existing shareholders and market conditions [3] - ST Zhongdi has decided to abandon the commercial opportunity for the Jiageng Ke Yi City land project, with the controlling shareholder planning to develop the project instead [4] - Xichang Electric Power expects a reduction of approximately 5.4 million yuan in net profit for 2025 due to adjustments in the time-of-use electricity pricing mechanism [5] Group 2 - Sanfu New Materials intends to invest 620 million yuan in a project for high-safety dry electrode battery key materials and high-frequency electronic information composite materials [6] - Weifu High-Tech's subsidiary plans to establish a joint venture with Baolong Technology to expand the active suspension motor hydraulic pump business [7] - Yulong Co., Ltd. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [8] Group 3 - Chen'an Technology's shareholder is transferring 6.27% of the company's shares to Hefei Guotou, aiming to introduce strategic investors [9] - Huamao Technology is planning to acquire a 100% stake in Fuchuang Youyue, with stock trading suspended for up to 10 trading days [11] - Baolong Technology's subsidiary will collaborate with Weifu High-Tech's subsidiary to develop core components for the active suspension system [12] Group 4 - Zhongnong Lihua intends to acquire at least 50% of Taizhou Agricultural Supplies, enhancing its product and service range [13] - Weiling Co., Ltd.'s subsidiary has successfully acquired 74.3% of Jiayu Mining for 220 million yuan, focusing on expanding into the non-ferrous metal resource sector [14][15] - Hengshi Technology's subsidiary has been approved for public transfer of shares on the New Third Board [16] Group 5 - Xiang Teng New Materials plans to acquire an additional 12.5% stake in its subsidiary Shanghai Shangda for 25.3 million yuan [17] - ST Texin has extended its employee stock ownership plan by 12 months, reflecting confidence in the company's long-term development [18] - Baili Electric has issued a risk warning regarding its stock price increase, indicating no significant changes in fundamentals [19] Group 6 - Hu Silicon Industry plans to acquire minority stakes in three semiconductor companies for approximately 7.04 billion yuan [20][21] - Demais plans to change its controlling shareholder, leading to a temporary suspension of stock trading [22] - FAW Fuwei has received a notice from a well-known new energy brand for a project expected to generate 1.06 billion yuan in total sales over its lifecycle [23] Group 7 - Hangyang Co. plans to establish a subsidiary for a large modular cryogenic equipment manufacturing project with an estimated investment of 557 million yuan [24] - Jiewate intends to acquire 40.89% of Tianyi Hexin for 319 million yuan, enhancing its product line in the signal chain category [25] - Dingxin Communications has elected a new chairman following the resignation of the previous chairman [26][27] Group 8 - Aofei Entertainment plans to invest 10 million yuan in a partnership to indirectly invest in AI robotics company Xuan Yuan Technology [28] - Huaxi Energy's controlling shareholder has been detained, but the company states that operations remain normal [29] - Yihe Jiaye will change its stock name to "Ruimaite" starting May 21 [30] Group 9 - Zhongjin Environment will change its name to "Southern Pump Industry" effective May 21 [31] - Hong Sifang's subsidiary plans to invest approximately 1.49 billion yuan in a new chemical materials and fertilizers industrial park [32] - Buchang Pharmaceutical's subsidiary has signed a research agreement for MF59 adjuvant with a pharmaceutical company [33] Group 10 - Hongjing Technology has signed a service contract worth 597 million yuan for a smart computing project [34] - Zhuojin Co. has won a bid for a soil remediation project worth 67.68 million yuan [35] - Xinjiang Jiaojian has been awarded a contract for a highway project valued at 451 million yuan [36] Group 11 - China National Materials Energy's subsidiary has signed a contract for an EPC project in Uzbekistan worth approximately 1.252 billion yuan [37] - Ruixin Microelectronics' shareholder plans to reduce its stake by up to 2% [38] - Shanghai Yizhong's shareholder also plans to reduce its stake by up to 2% [39] Group 12 - Sanyou Medical's controlling shareholder plans to reduce its stake by up to 1.44% [40] - Hangdian Co.'s controlling shareholder plans to reduce its stake by up to 1.93% [41] - Shangwei New Materials' shareholder plans to reduce its stake by up to 3% [42] Group 13 - Mingchen Health plans to repurchase shares worth between 30 million and 50 million yuan [43] - Jiuhua Tourism plans to raise up to 500 million yuan through a private placement for various projects [44] - Yuegui Co. plans to raise up to 900 million yuan for several projects [46]

二、监事会会议审议情况 证券代码：001373 证券简称：翔腾新材 公告编号：2025-026 江苏翔腾新材料股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、监事会会议召开情况 江苏翔腾新材料股份有限公司（以下简称"公司"或"翔腾新材"）第二届监事会 第八次会议于 2025 年 5 月 20 日在南京市栖霞区栖霞街道广月路 21 号会议室以现 场的方式召开，会议应出席监事 3 人，实际出席监事 3 人。会议由监事会主席黄龙 先生主持。会议通知已于 2025 年 5 月 16 日以电子邮件的方式向全体监事送达。 本次监事会会议的召开符合《中华人民共和国公司法》和《公司章程》的有关规定， 会议合法、有效。 本议案无需提交股东大会审议。 三、备查文件 特此公告。 江苏翔腾新材料股份有限公司 监事会 （一）审议通过《关于收购控股子公司少数股东股权暨关联交易的议案》 监事会同意公司以自有资金人民币 2,530.00 万元的价格收购徐捷先生持有的 控股子公司上海尚达电子绝缘材料有限公司（以下简称"上海尚达"）12.50%股权。 本次收购完成后，公司持有上 ...

光大证券股份有限公司关于江苏翔腾新材料股份有限公司 收购控股子公司少数股东股权暨关联交易的核查意见 光大证券股份有限公司（以下简称"光大证券""保荐机构"）作为江苏翔 腾新材料股份有限公司（以下简称"翔腾新材""公司"）持续督导的保荐机构， 根据《证券发行上市保荐业务管理办法》《深圳证券交易所股票上市规则》《深 圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等相关 法律、法规和规范性文件的规定，对翔腾新材收购控股子公司少数股东股权暨关 联交易的事项进行了审慎核查，核查情况如下： 一、交易概述 （一）根据公司整体战略布局及业务发展需要，为进一步优化整合产业资源， 提高管理效率和公司综合竞争力，公司拟以自有资金人民币 2,530.00 万元收购徐 捷先生持有的控股子公司上海尚达电子绝缘材料有限公司（以下简称"上海尚达" 或"标的公司"）12.50%股权。 本次股权收购完成后，公司持有上海尚达股权比例将由 75%增至 87.50%， 本次交易不会导致公司合并报表范围发生变化。 （二）鉴于上海尚达是公司重要子公司，徐捷先生持有上海尚达少数股权， 依据谨慎性原则，本次交易按照关联交易履行审议及披露 ...

证券代码：001373 证券简称：翔腾新材 公告编号：2025-027 江苏翔腾新材料股份有限公司 关于收购控股子公司少数股东股权暨关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、交易概述 1、根据江苏翔腾新材料股份有限公司（以下简称"翔腾新材"或"公司"）整体战略 布局及业务发展需要，为进一步优化整合产业资源，提高管理效率和公司综合竞争力， 公司拟以自有资金人民币 2,530.00 万元收购徐捷先生持有的控股子公司上海尚达电子 绝缘材料有限公司（以下简称"上海尚达"或"标的公司"）12.50%股权。 本次收购完成后，公司持有上海尚达股权比例将由 75%增至 87.50%，本次交易不 会导致公司合并报表范围发生变化。 2、鉴于上海尚达是公司重要子公司，徐捷先生持有上海尚达少数股权，依据谨慎 性原则，本次交易按照关联交易履行审议及披露程序。 （二）关联关系情况说明 3、公司于 2025 年 5 月 20 日分别召开了第二届董事会第八次会议、第二届监事会 第八次会议，审议通过了《关于收购控股子公司少数股东股权暨关联交易的议案》。本 次关联交易事 ...

证券代码：001373 证券简称：翔腾新材 公告编号：2025-026 第二届监事会第八次会议决议公告 江苏翔腾新材料股份有限公司 （一）审议通过《关于收购控股子公司少数股东股权暨关联交易的议案》 监事会同意公司以自有资金人民币 2,530.00 万元的价格收购徐捷先生持有的 控股子公司上海尚达电子绝缘材料有限公司（以下简称"上海尚达"）12.50%股权。 本次收购完成后，公司持有上海尚达股权比例将由 75%增至 87.50%，本次交易不 会导致公司合并报表范围发生变化。 《关于收购控股子公司少数股东股权暨关联交易的公告》详见同日刊登在中 国证监会指定信息披露媒体巨潮资讯网的相关公告。 本公司及监事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、监事会会议召开情况 江苏翔腾新材料股份有限公司（以下简称"公司"或"翔腾新材"）第二届监事会 第八次会议于 2025 年 5 月 20 日在南京市栖霞区栖霞街道广月路 21 号会议室以现 场的方式召开，会议应出席监事 3 人，实际出席监事 3 人。会议由监事会主席黄龙 先生主持。会议通知已于 2025 年 5 月 16 日以电 ...

江苏翔腾新材料股份有限公司 证券代码：001373 证券简称：翔腾新材 公告编号：2025-025 二、董事会会议审议情况 （一）审议通过《关于收购控股子公司少数股东股权暨关联交易的议案》 董事会同意公司以自有资金人民币 2,530.00 万元的价格收购徐捷先生持有的 控股子公司上海尚达电子绝缘材料有限公司（以下简称"上海尚达"）12.50%股权。 本次收购完成后，公司持有上海尚达股权比例将由 75%增至 87.50%，本次交易不 会导致公司合并报表范围发生变化。 董事会审议该议案前，公司已召开独立董事专门会议审议该议案，对本议案发 表了同意的意见，并一致同意将该议案提交董事会审议。 《关于收购控股子公司少数股东股权暨关联交易的公告》详见同日刊登在中 国证监会指定信息披露媒体巨潮资讯网的相关公告。 第二届董事会第八次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 三、备查文件 一、董事会会议召开情况 江苏翔腾新材料股份有限公司（以下简称"公司"或"翔腾新材"）第二届董事会 第八次会议于 2025 年 5 月 20 日在南京市栖霞区栖霞街道广月路 ...

德恒上海律师事务所 关于 江苏翔腾新材料股份有限公司 2024 年度股东大会之 见证意见 上海市东大名路 501 号上海白玉兰广场办公楼 23 层 电话：021-55989888/55989666 传真：021-5598 9898 邮编：200080 德恒上海律师事务所 关于江苏翔腾新材料股份有限公司 2024 年度股东大会之见证意见 德恒上海律师事务所 关于 江苏翔腾新材料股份有限公司 德恒 02G20240187-00002 号 致：江苏翔腾新材料股份有限公司 德恒上海律师事务所（以下简称"本所"）接受江苏翔腾新材料股份有限公 司（以下简称"公司"）的委托，指派本所见证律师列席公司于 2025 年 5 月 19 日14点50分在南京市栖霞区栖霞街道广月路江苏翔腾新材料股份有限公司召开 的 2024 年度股东大会（以下简称"本次股东大会"），就召开本次股东大会进 行见证并出具本见证意见。 本所见证律师依据本见证意见出具日前已经发生或存在的事实和《中华人民 共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以下简 称《证券法》）、《上市公司股东会规则》（以下简称《股东会规则》）等法律、 法规和规 ...